ETHEL DAWLEY: Open Payments
NPI 1477710812 · BRAINTREE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 30 payments from 10 companies in 2025. Trend: 2023 $786 · 2024 $515 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $244 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $129 |
| Alkermes, Inc. | 4 | $81 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| Corium, LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
Products named: REXULTI, CAPLYTA, INGREZZA, Auvelity, FANAPT, ARISTADA, VIVITROL, Azstarys.
Industry payments across MA — which companies pay providers there.
